Does the Selective Progesterone Receptor Modulator Ulipristal Normalize the Uterine Cavity in Women with Leiomyoma

被引：0
|
作者：
Levy, Gary [1 ]
Avila, Nilo [2 ]
Armstrong, Alicia Y. [1 ]
Nieman, Lynnette [1 ]
机构：
[1] Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Program Reprod & Adult Endocrinol, NIH, Bethesda, MD USA
[2] NIH, Dept Radiol, Mark O Hatfield Clin Res Ctr, Bethesda, MD 20892 USA
来源：
REPRODUCTIVE SCIENCES | 2011年 / 18卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R71 [妇产科学];
学科分类号：
100211 ;
摘要：
T081
引用
收藏
页码：95A / 95A
页数：1
相关论文
共 50 条
  • [41] Pharmacokinetics and safety of the selective progesterone receptor modulator vilaprisan in healthy postmenopausal women
    Schultze-Mosgau, Marcus-Hillert
    Schuett, Barbara
    Hafner, Frank-Thorsten
    Zollmann, Frank
    Kaiser, Andreas
    Hoechel, Joachim
    Rohde, Beate
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS, 2017, 55 (01) : 16 - 24
  • [42] The progesterone-receptor modulator, ulipristal acetate, drastically lowers breast cell proliferation
    Westhoff, Carolyn L.
    Guo, Hua
    Wang, Zhong
    Hibshoosh, Hanina
    Polaneczky, Margaret
    Pike, Malcolm C.
    Ha, Richard
    BREAST CANCER RESEARCH AND TREATMENT, 2022, 192 (02) : 321 - 329
  • [43] Selective Progesterone Receptor Modulators for the Medical Treatment of Uterine Fibroids with a Focus on Ulipristal Acetate (vol 2018, 1374821, 2018)
    Rabe, Thomas
    Saenger, Nicole
    Ebert, Andreas D.
    Roemer, Thomas
    Tinneberg, Hans-Rudolf
    De Wilde, Rudy Leon
    Wallwiener, Markus
    BIOMED RESEARCH INTERNATIONAL, 2018, 2018
  • [44] Vilaprisan, a New Selective Progesterone Receptor Modulator in Uterine Fibroid Pharmacotherapy-Will it Really be a Breakthrough?
    Ciebiera, Michal
    Vitale, Salvatore G.
    Ferrero, Simone
    Vilos, George A.
    Barra, Fabio
    Caruso, Salvatore
    Lagana, Antonio S.
    Sierant, Antoni
    Cianci, Antonio
    Jakiel, Grzegorz
    CURRENT PHARMACEUTICAL DESIGN, 2020, 26 (03) : 300 - 309
  • [45] The progesterone-receptor modulator, ulipristal acetate, drastically lowers breast cell proliferation
    Carolyn L. Westhoff
    Hua Guo
    Zhong Wang
    Hanina Hibshoosh
    Margaret Polaneczky
    Malcolm C. Pike
    Richard Ha
    Breast Cancer Research and Treatment, 2022, 192 : 321 - 329
  • [46] Selective progesterone receptor modulators for fertility preservation in women with symptomatic uterine fibroids
    Ali, Mohamed
    Al-Hendy, Ayman
    BIOLOGY OF REPRODUCTION, 2017, 97 (03) : 337 - 352
  • [47] Uterine NK Cells Regulate Endometrial Bleeding in Women and Are Suppressed by the Progesterone Receptor Modulator Asoprisnil
    Wilkens, Julia
    Male, Victoria
    Ghazal, Peter
    Forster, Thorsten
    Gibson, Douglas A.
    Williams, Alistair R. W.
    Brito-Mutunayagam, Savita L.
    Craigon, Marie
    Lourenco, Paula
    Cameron, Iain T.
    Chwalisz, Kristof
    Moffett, Ashley
    Critchley, Hilary O. D.
    JOURNAL OF IMMUNOLOGY, 2013, 191 (05): : 2226 - 2235
  • [48] Estrogen and progesterone receptor expression in different molecular uterine leiomyoma subclasses
    Makinen, Netta
    Pasanen, Annukka
    Heinonen, Hanna-Riikka
    Kampjarvi, Kati
    Bramante, Simona
    Mehine, Miika
    Jalkanen, Jyrki
    Heikinheimo, Oskar'
    Sjoberg, Jari
    Butzow, Ralf
    Aaltonen, Lauri
    CANCER RESEARCH, 2016, 76
  • [49] A selective estrogen receptor modulator designed for the treatment of uterine leiomyoma with unique tissue specificity for uterus and ovaries in rats
    Hummel, CW
    Geiser, AG
    Bryant, HU
    Cohen, IR
    Dally, RD
    Fong-, KC
    Frank, SA
    Hinklin, R
    Jones, SA
    Lewis, G
    McCann, DJ
    Rudmann, DG
    Shepherd, TA
    Tian, HQ
    Wallace, OB
    Wang, MM
    Wang, Y
    Dodge, JA
    JOURNAL OF MEDICINAL CHEMISTRY, 2005, 48 (22) : 6772 - 6775
  • [50] Effect of the Novel Selective Progesterone Receptor Modulator Vilaprisan on Ovarian Activity in Healthy Women
    Schuett, Barbara
    Schultze-Mosgau, Marcus-Hillert
    Draeger, Corinna
    Chang, Xinying
    Loewen, Stephanie
    Kaiser, Andreas
    Rohde, Beate
    JOURNAL OF CLINICAL PHARMACOLOGY, 2018, 58 (02): : 228 - 239
12345